health 36

Dr. Holly Colognato and MD/PhD Scholar Himanshu Sharma view stem cell area of interest cells which are affected when brains lack the muscle cell receptor dystroglycan . Credit score: Picture courtesy of Stony Brook College Researchers at Stony Brook College have found that dystroglycan, a muscle cell receptor whose dysfunction causes muscular dystrophy, really has a essential position in mind improvement. The discovering, revealed within the journal  Developmental Cell , could assist to elucidate why a subset of kids born with a dysfunction of this muscle receptor, even have neurological issues that may embrace seizures, mental incapacity, autism, and extreme studying disabilities. Within the new child mind, one of many essential modifications that happens is that specialised pockets type that serve to accommodate and nurture neural stem c...

Researchers from Princeton College and the Mayo Clinic Most cancers Middle have discovered particular situations -- tumor hardness and an absence of oxygen on the tumor's core -- that result in breast-cancer development in laboratory cultures. The illustration above exhibits non-spreading most cancers cells with out these situations (left), whereas these which are stiff and hypoxic (proper) are starting to unfold. Credit score: Picture courtesy of Celeste Nelson, Division of Chemical and Organic Engineering When Hippocrates first described most cancers round 400 B.C., he referred to the illness's telltale tumors as "karkinos" -- the Greek phrase for crab. The "Father of Western Medication" seemingly famous that most cancers's creeping projections mirrored sure crustaceans, and the tumors' attribute hardness res...

In a description of the work, published online Sept. 12 in the  Journal of Cerebral Blood Flow and Metabolism , they express hope that the tests in anesthetized dogs and pigs are a step toward human trials of a technique to treat Parkinson's disease, stroke, and other brain damaging disorders. "Although stem cell-based therapies seem very promising, we've seen many clinical trials fail. In our view, what's needed are tools to precisely target and deliver stem cells to larger areas of the brain," says Piotr Walczak, M.D., Ph.D., associate professor of radiology at the Johns Hopkins University School of Medicine's Institute for Cell Engineering. The therapeutic promise of human stem cells is derived from their ability to develop into any kind of cell and, in theory, regenerate injured or diseased tissues ranging from the insulin-making islet cells of the pancreas that are lost in type 1 diabetes to the dopamine-producing brain cells that die off in Parkinson...

Insoo Hyun, PhD, associate professor of bioethics, urges such research to proceed only after "knowing the right and wrong ways to treat sentient beings according to complexities of their attributes." Hyun's recommendations appear in the journal's September 15th issue and come a week after the National Institutes of Health closed a month-long public comment period on proposed new regulations, widely expected to be adopted, that would lift a moratorium that currently forbids federal funding for chimera embryo research. For decades, research has taken place on animal-human chimeras (after a Greek mythological figure with the head of a lion, the body of a goat, and the tail of a serpent), without much controversy in the United States, such as in the case of mice transplanted with human cancer cells. However, concerns have arisen about research using human pluripotent stem cells, the focus of the current NIH moratorium. These cells are made from skin or blood cells ...